Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
about
Managing the drug treatment of rheumatoid arthritis.Abnormal Glucose Metabolism in Rheumatoid ArthritisDenosumab: targeting the RANKL pathway to treat rheumatoid arthritis.Review of the bioanalytical methods for the determination of methotrexate and its metabolites in in vitro, preclinical and clinical studies: Case studies and perspectives.Effect of Nigella sativa (black seeds) against methotrexate-induced nephrotoxicity in mice.Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis.Hydroxychloroquine retinopathy.Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.In-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.Risk of liver disease in methotrexate treated patients.Optimizing treatment with tumour necrosis factor inhibitors in rheumatoid arthritis-a proof of principle and exploratory trial: is dose tapering practical in good responders?Effect of Qianghuo Erhuang Decoction on T Regulatory and T Helper 17 Cells in Treatment of Adjuvant-induced Arthritis in Rats.Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm.Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications.Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons.The road from development to approval: evaluating the body of evidence to confirm biosimilarity.Denosumab, cortical bone and bone erosions in rheumatoid arthritis.Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study.Planning a future randomized clinical trial based on a network of relevant past trials.
P2860
Q33611369-20D4F716-CC48-48DA-A1B8-849F95D3AB8FQ33654451-9AD3B32F-112C-488A-BFCF-A9D79D3F165FQ34545263-D332BF81-2403-4793-B03A-70B68B9F29A8Q36131520-3DCD04C7-3925-477B-81B3-68F8A3138A81Q37621165-5E76EBEB-1F4C-42D4-8755-75B18C89EB94Q37745676-DC08787D-FB83-4A66-9AB9-E1A44DC8483DQ38847005-37895FBF-4730-4841-A7F1-35FAE288061EQ38991972-E106F579-7DC2-4347-8BB9-2FFCBFF452BFQ39107181-CD78A191-E420-47D9-BD14-613BCBC64D92Q39172826-3BCC83E6-114F-4E3D-8228-6FC3FCE3822DQ40045451-367D213C-6575-4E8C-B456-04C531F82349Q40593579-73D3ABC6-9429-4E9B-81EA-8AA146A2D910Q41808297-FE790C8C-07FC-4612-90E6-D5E939930DCCQ42062698-8FCAC0F5-93BB-4E14-ADDB-BCAE47AD9833Q42363647-C9312256-8CB0-445D-B5DC-BAFD82794560Q47102960-5B82E324-8F69-40B3-9638-767641A054F0Q47144717-E8422EDE-CCCF-4BB3-B0B3-2F24327B9EA6Q47688424-04371D4C-D609-41AC-8FEB-A0570928684EQ47800990-006D862E-2300-4E9A-BB03-0A8CDCAE5EC1Q47807650-3BB4DD74-1FCD-4DAF-8763-A79B8813908EQ47950956-A2BCA167-F3AA-4074-8727-03B1B2E0526DQ48187901-E36120E9-73D7-4BB7-98EF-A1DF34E4F074Q50108347-36EB488A-7AA9-49B8-BFC1-B9C93F165385Q51362330-1D9656F9-1A4A-495A-A72F-68DF53E8EBC7Q55632617-2D5AFE96-4D35-42E0-8381-A7DB4DF7EA0C
P2860
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Methotrexate monotherapy and m ...... view and network meta-analysis
@ast
Methotrexate monotherapy and m ...... view and network meta-analysis
@en
Methotrexate monotherapy and m ...... view and network meta-analysis
@nl
type
label
Methotrexate monotherapy and m ...... view and network meta-analysis
@ast
Methotrexate monotherapy and m ...... view and network meta-analysis
@en
Methotrexate monotherapy and m ...... view and network meta-analysis
@nl
prefLabel
Methotrexate monotherapy and m ...... view and network meta-analysis
@ast
Methotrexate monotherapy and m ...... view and network meta-analysis
@en
Methotrexate monotherapy and m ...... view and network meta-analysis
@nl
P2860
P31
P50
P921
P3181
P356
P1433
P1476
Methotrexate monotherapy and m ...... view and network meta-analysis
@en
P2093
Cheryl Barnabe
P2860
P3181
P356
10.1136/BMJ.I1777
P407
P5008
P577
2016-04-21T00:00:00Z